Skip to main content
. 2016 May 2;11(5):e0152306. doi: 10.1371/journal.pone.0152306

Table 1. Baseline characteristics categorized by 24h sodium excretion.

24h urinary sodium excretion
Variable Overall <3.0 g/day 3.0–4.0 g/day 4.0–5.0 g/day 5.0–6.0 g/day >6.0 g/day P-value
Number of patients 1230 220 274 333 222 181
24h urinary sodium excretion, g/day 4.50 (1.64) 2.46 (0.48) 3.52 (0.27) 4.47 (0.30) 5.45 (0.29) 7.36 (1.35) <0.001
Age, years 62.2 (10.9) 65.2 (9.9) 63.6 (10.3) 61.9 (10.6) 60.8 (11.7) 58.4 (11.1) <0.001
Male, n (%) 651 (52.9) 92 (41.8) 133 (48.5) 169 (50.8) 127 (57.2) 130 (71.8) <0.001
Height, cm 159.0 (9.1) 155.8 (8.5) 157.7 (9.2) 158.7 (8.6) 160.4 (8.6) 163.7 (9.3) <0.001
Weight, kg 61.5 (11.6) 56.8 (9.8) 59.5 (11.1) 60.6 (10.0) 64.2 (11.3) 68.8 (13.6) <0.001
BMI, kg/m2 24.2 (3.6) 23.3 (3.4) 23.8 (3.5) 24.0 (3.5) 24.9 (3.6) 25.5 (3.8) <0.001
Systolic BP, mmHg 131.7 (17.5) 130.5 (18.6) 132.2 (18.0) 131.3 (17.4) 131.9 (16.9) 133.3 (16.3) 0.570
Diastolic BP, mmHg 72.6 (12.2) 71.0 (12.5) 71.5 (11.5) 72.2 (11.6) 73.0 (12.4) 76.7 (12.7) <0.001
Type 2 diabetes, n (%) 1112 (90.4) 191 (86.8) 247 (90.1) 300 (90.1) 206 (92.8) 168 (92.8) 0.199
Diabetes duration, years 12.0 (8.0) 13.4 (8.6) 11.9 (8.0) 12.2 (8.3) 11.3 (7.3) 11.0 (7.5) 0.022
Diabetic retinopathy, n (%) 479 (38.9) 91 (41.4) 104 (38.0) 127 (38.1) 92 (41.4) 65 (35.9) 0.731
History of CVD, n (%) 250 (20.3) 64 (29.1) 57 (20.8) 59 (17.7) 45 (20.3) 25 (13.8) 0.002
Oral hypoglycemic agent, n (%) 818 (66.5) 132 (60.0) 180 (65.7) 225 (67.6) 150 (67.6) 131 (72.4) 0.119
Insulin, n (%) 408 (33.2) 88 (40.0) 87 (31.8) 110 (33.0) 73 (32.9) 50 (27.6) 0.116
RAAS blockade, n (%) 611 (49.7) 114 (51.8) 141 (51.5) 161 (48.3) 109 (49.1) 86 (47.5) 0.852
Calcium channel blocker, n (%) 456 (37.1) 93 (42.3) 108 (39.4) 112 (33.6) 81 (36.5) 62 (34.3) 0.237
Diuretics, n (%) 137 (11.1) 23 (10.5) 35 (12.8) 39 (11.7) 21 (9.5) 19 (10.5) 0.798
Statin, n (%) 440 (35.8) 81 (36.8) 106 (38.7) 119 (35.7) 73 (32.9) 61 (33.7) 0.688
Total protein, g/dl 7.48 (0.45) 7.51 (0.41) 7.50 (0.46) 7.45 (0.44) 7.50 (0.47) 7.46 (0.44) 0.434
Albumin, g/dl 4.39 (0.26) 4.37 (0.25) 4.40 (0.26) 4.38 (0.27) 4.40 (0.28) 4.43 (0.27) 0.138
Uric acid, mg/dl 5.07 (1.37) 5.21 (1.35) 5.08 (1.40) 4.93 (1.38) 5.07 (1.34) 5.14 (1.38) 0.171
Creatinine, mg/dl 0.72 (0.19) 0.74 (0.20) 0.72 (0.19) 0.72 (0.20) 0.71 (0.18) 0.72 (0.15) 0.422
eGFR, ml/min/1.73m2 78.6 (19.5) 73.1 (18.3) 76.9 (18.6) 78.6 (19.5) 82.1 (19.9) 83.6 (19.7) <0.001
HbA1c, % 7.26 (0.95) 7.21 (0.92) 7.25 (0.99) 7.25 (0.93) 7.29 (0.96) 7.28 (0.97) 0.927
Serum sodium, mEq/l 139.6 (1.8) 139.7 (2.0) 139.7 (2.0) 139.6 (1.8) 139.50 (1.7) 139.4 (1.6) 0.376
Serum potassium, mEq/l 4.44 (0.37) 4.42 (0.38) 4.42 (0.36) 4.43 (0.39) 4.46 (0.38) 4.46 (0.34) 0.547
Serum chloride, mEq/l 104.3 (2.4) 104.6 (2.4) 104.4 (2.5) 104.4 (2.4) 104.1 (2.1) 103.9 (2.2) 0.028
Total cholesterol, mg/dl 198.8 (34.7) 199.4 (34.1) 199.5 (34.0) 199.0 (36.4) 197.8 (34.1) 198.2 (34.3) 0.980
HDL cholesterol, mg/dl 53.3 (14.0) 54.2 (15.0) 53.9 (12.9) 53.8 (14.3) 52.7 (14.6) 51.3 (12.6) 0.198
24h urinary albumin excretion, mg/day 44.4 (117.9) 38.5 (86.7) 40.1 (149.7) 48.5 (132.2) 51.1 (99.4) 42.6 (85.4) 0.719
24h urinary potassium excretion, g/day 2.14 (0.77) 1.71 (0.65) 1.97 (0.61) 2.11 (0.65) 2.35 (0.72) 2.74 (0.91) <0.001

Categorical variables are expressed as the number (%) and continuous variables are expressed as the mean (SD).

BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; RAAS, renin-angiotensin-aldosterone system; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein